A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of Hantaan virus induced protective immunity in mice

Virology Journal

Volumn 10, Issue , 2013, Pages

  Yu, Lan ^a   Bai, Wentao ^b   Wu, Xingan ^a   Zhang, Liang ^a   Zhang, Lei ^a   Li, Puyuan ^a   Wang, Fang ^a   Liu, Ziyu ^a   Zhang, Fanglin ^a   Xu, Zhikai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Glycoprotein; Hantaan virus; Protective immunity; Recombinant pseudotyped lentivirus

Indexed keywords

GAMMA INTERFERON; HANTAAN VIRUS VACCINE; INACTIVATED VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LENTIVIRUS VECTOR; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DRUG EFFICACY; FEMALE; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SPLEEN CELL; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

HANTAAN VIRUS; HANTAVIRUS; LENTIVIRUS; MUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CYTOKINES; DRUG CARRIERS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC VECTORS; HANTAAN VIRUS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; NEUTRALIZATION TESTS; SPLEEN; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84884948933     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-301     Document Type: Article

References (42)

1. Structural studies of Hantaan virus. Battisti AJ, Chu YK, Chipman PR, Kaufmann B, Jonsson CB, Rossmann MG, J Virol 2011 85 835 841 10.1128/JVI.01847-10 21068243
2. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Lober C, Anheier B, Lindow S, Klenk HD, Feldmann H, Virology 2001 289 224 229 10.1006/viro.2001.1171 11689045 (Pubitemid 33141002)
3. Hantaviruses: a global disease problem. Schmaljohn C, Hjelle B, Emerg Infect Dis 1997 3 95 104 10.3201/eid0302.970202 9204290 (Pubitemid 127431667)
4. Hantavirus. Clement JP, Antiviral Res 2003 57 121 127 10.1016/S0166-3542(02)00205-X 12615308 (Pubitemid 36254726)
5. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ, Science 1993 262 914 917 10.1126/science.8235615 8235615 (Pubitemid 24014083)
6. Hantavirus pulmonary syndrome, United States, 1993-2009. MacNeil A, Ksiazek TG, Rollin PE, Emerg Infect Dis 2011 17 1195 1201 10.3201/eid1707.101306 21762572
7. Hantavirus infections in humans and animals, China. Zhang YZ, Zou Y, Fu ZF, Plyusnin A, Emerg Infect Dis 2010 16 1195 1203 10.3201/eid1608.090470 20678311
8. Vaccines against hantaviruses. Hjelle B, Expert Rev Vaccines 2002 1 373 384 10.1586/14760584.1.3.373 12901576 (Pubitemid 36559872)
9. Recent approaches in hantavirus vaccine development. Maes P, Clement J, Van Ranst M, Expert Rev Vaccines 2009 8 67 76 10.1586/14760584.8.1.67 19093774
10. Hantavirus immunology. Khaiboullina SF, St Jeor SC, Viral Immunol 2002 15 609 625 10.1089/088282402320914548 12513931 (Pubitemid 35448774)
11. Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. Arikawa J, Schmaljohn AL, Dalrymple JM, Schmaljohn CS, J Gen Virol 1989 70 Pt 3 615 624 2471792 (Pubitemid 19078648)
12. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM, J Virol 1990 64 3162 3170 1972201 (Pubitemid 20219517)
13. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. Hooper JW, Custer DM, Thompson E, Schmaljohn CS, J Virol 2001 75 8469 8477 10.1128/JVI.75.18.8469-8477.2001 11507192 (Pubitemid 32768951)
14. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C, Vaccine 2008 26 5177 5181 10.1016/j.vaccine.2008.03.097 18482782
15. Immunization delivered by lentiviral vectors for cancer and infectious diseases. Hu B, Tai A, Wang P, Immunol Rev 2011 239 45 61 10.1111/j.1600-065X. 2010.00967.x 21198664
16. Lentiviral vectors for immunization: an inflammatory field. Pincha M, Sundarasetty BS, Stripecke R, Expert Rev Vaccines 2010 9 309 321 10.1586/erv.10.9 20218859
17. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus. Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, Charneau P, J Gene Med 2006 8 265 274 10.1002/jgm.837 16308885
18. Detection of the specific antigens in the tissues of the C57BL/6 mice infected with Hantavirus. Cheng L-f, Bai L, Li K, Li P-y, Hu G, Yu L, Wu X-a, Xu Z-k, Zhang F-l, J Trop Med 2011 11 481 482
19. Review of an inactivated vaccine against hantaviruses. Cho HW, Howard CR, Lee HW, Intervirology 2002 45 328 333 10.1159/000067925 12602351 (Pubitemid 36173442)
20. The expression and genetic immunization of chimeric fragment of Hantaan virus M and S segments. Zhang FL, Wu XA, Luo W, Bai WT, Liu Y, Yan Y, Wang HT, Xu ZK, Biochem Biophys Res Commun 2007 354 858 863 10.1016/j.bbrc.2007.01.020 17266922 (Pubitemid 46216212)
21. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW, J Virol 2003 77 9894 9905 10.1128/JVI.77.18.9894-9905.2003 12941899 (Pubitemid 37122070)
22. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS, Virology 1999 255 269 278 10.1006/viro.1998.9586 10069952 (Pubitemid 29393338)
23. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. Hooper JW, Ferro AM, Wahl-Jensen V, J Virol 2008 82 1332 1338 10.1128/JVI.01822-07 18032485
24. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arikawa J, Yao JS, Yoshimatsu K, Takashima I, Hashimoto N, Arch Virol 1992 126 271 281 10.1007/BF01309700 1381911
25. Recombinant vesicular stomatitis viruses from DNA. Lawson ND, Stillman EA, Whitt MA, Rose JK, Proc Natl Acad Sci USA 1995 92 4477 4481 10.1073/pnas.92.10.4477 7753828
26. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Whelan SP, Ball LA, Barr JN, Wertz GT, Proc Natl Acad Sci USA 1995 92 8388 8392 10.1073/pnas.92.18.8388 7667300
27. A third-generation lentivirus vector with a conditional packaging system. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L, J Virol 1998 72 8463 8471 9765382 (Pubitemid 28471781)
28. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D, J Virol 1998 72 9873 9880 9811723 (Pubitemid 28520853)
29. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Trono D, Gene Ther 2000 7 20 23 10.1038/sj.gt.3301105 10680011 (Pubitemid 30077144)
30. Use of HIV as a gene transfer vector. Pluta K, Kacprzak MM, Acta Biochim Pol 2009 56 531 595 19936329
31. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Huret C, Desjardins D, Miyalou M, Levacher B, Amadoudji Zin M, Bonduelle O, Combadiere B, Dalba C, Klatzmann D, Bellier B, Vaccine 2013 31 1540 1547 10.1016/j.vaccine.2012.05.025 22634300
32. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. Lee BH, Yoshimatsu K, Araki K, Okumura M, Nakamura I, Arikawa J, Vaccine 2006 24 2928 2934 10.1016/j.vaccine.2005.12.040 16426712
33. Analysis of the immune response to Hantaan virus nucleocapsid protein C-terminal-specific CD8(+) T cells in patients with hemorrhagic fever with renal syndrome. Wang PZ, Huang CX, Zhang Y, Li ZD, Yo HT, Zhang Y, Jia ZS, Wang JP, Lian JQ, Sun YT, Bai XF, Viral Immunol 2009 22 253 260 10.1089/vim.2008.0097 19594396
34. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. Wang M, Wang J, Zhu Y, Xu Z, Yang K, Yang A, Jin B, J Infect Dis 2009 199 188 195 10.1086/595834 19072554
35. Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination. Woo GJ, Chun EY, Kim KH, Kim W, J Microbiol 2005 43 537 545 16410771 (Pubitemid 43096480)
36. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Wang M, Pennock DG, Spik KW, Schmaljohn CS, Virology 1993 197 757 766 10.1006/viro.1993.1652 7504368 (Pubitemid 23349575)
37. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Xu Z, Wei L, Wang L, Wang H, Jiang S, Biochem Biophys Res Commun 2002 298 552 558 10.1016/S0006-291X(02)02491-9 12408987 (Pubitemid 35333693)
38. Preliminary study on structural protein of epidemic hemorrhagic fever virus using monoclonal antibodies. Liang MF, Song G, Hang CS, Li DX, Qiu HL, Chinese Journal of Virology 1989 5 217 224
39. Nucleotide sequence of the M segment of the genomic RNA of Hantaan virus 76-118. Yoo DW, Kang CY, Nucleic Acids Res 1987 15 6299 6300 10.1093/nar/15.15.6299 3114716
40. Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice. Li PY, Yu L, Wu XA, Bai WT, Li K, Wang HT, Hu G, Zhang L, Zhang FL, Xu ZK, J Virol Methods 2012 179 90 96 10.1016/j.jviromet.2011.10.005 22015676
41. Comparison of the micro cell culture test and the plaque assay for Hemorrhagic Fever with Renal Syndrome Virus and its neutralizing antibody. Xu ZK, Zou HS, Wang LY, Wang HT, Xiao Y, Wang MX, Chin J Exp Clin Virol 1995 9 126 128
42. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7. Li K, Li PY, Wu XA, Zhang L, Liu ZY, Yu L, Zhang L, Cheng LF, Bai WT, Zhang FL, Xu ZK, Int J Mol Med 2013 Epub ahead of print